1-3 of 3
Thomas Shea
Close
Sort by
Journal Articles

Adhesion Molecule Blockade with the Humanized Anti-LFA-1 Monoclonal Antibody Efalizumab Improves Steroid Refractory Acute and Chronic Graft-Versus-Host Disease of the Skin

James M. Coghill, MD, Kristine E. Nograles, MD, James G. Krueger, MD, PhD, Amy S. Coghill, RN, MSN, Jonathan S. Serody, MD, PhD, Anastasia Ivanova, PhD, Julia Whitley, BS, Donald Gabriel, MD, PhD, Terrance Comeau, MD, Thomas Shea, MD
Journal: Blood
Blood (2008) 112 (11): 4350.
https://doi.org/10.1182/blood.V112.11.4350.4350
Published: 2008
Journal Articles

Low Incidence of GVHD and Treatment-Related Morbidity (TRM) with Intermediate Doses of Continuous Infusion IV Busulfan and Daily Fludarabine with Individualized Doses of Alemtuzamab for Matched Related (MRD) and Unrelated (MUD) Transplant Pts with High-Risk Hematologic Malignancies.

Thomas Shea, MD, Jonathan Serody, MD, PhD, Don Gabriel, MD, PhD, Terrance Comeau, MD, Anastasia Ivanova, PhD, Dominic Moore, PhD, Robert Irons, PA, Whitley Julia, BS, Sharf Andrew, RN, Cherie Dunphy, MD, Brecher Mark, MD
Journal: Blood
Blood (2007) 110 (11): 4940.
https://doi.org/10.1182/blood.V110.11.4940.4940
Published: 2007
Journal Articles

A Randomized Comparison of Induction Therapy for Untreated Acute Myeloid Leukemia (AML) in Patients < 60 Years Using P-Glycoprotein (Pgp) Modulation with Valspodar (PSC833): Preliminary Results of Cancer and Leukemia Group B Study 19808.

Jonathan E. Kolitz, Stephen L. George, Guido Marcucci, Ravi Vij, Bayard L. Powell, Steven L. Allen, Daniel J. De Angelo, Thomas Shea, Wendy Stock, Vera Hars, Eva Hoke, James W. Vardiman, Clara D. Bloomfield, Richard A. Larson
Journal: Blood
Blood (2005) 106 (11): 407.
https://doi.org/10.1182/blood.V106.11.407.407
Published: 2005